A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent Asthma

Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection

NCT04445038 ·Status: UNKNOWN ·Phase: PHASE1

A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects with Mild Allergic Diseases

NCT05061524 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Efficacy of CAT-354

NCT00873860 ·Status: COMPLETED ·Phase: PHASE2

Study of Mepolizumab Safety Syringe in Asthmatics

NCT03021304 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

NCT05243680 ·Status: COMPLETED ·Phase: PHASE3

A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL

NCT01544348 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

NCT06987539 ·Status: RECRUITING ·Phase: PHASE2

Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.

NCT00500539 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis

NCT05152563 ·Status: WITHDRAWN ·Phase: PHASE3

Long Term Special Drug Use Investigation of Mepolizumab

NCT03028480 ·Status: COMPLETED

Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects

NCT00634569 ·Status: COMPLETED ·Phase: PHASE4

A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy

NCT00639691 ·Status: COMPLETED ·Phase: PHASE4

Golimumab for the Treatment of Refractory Behcet's Uveitis

NCT04218565 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis

NCT04021862 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3549492 in Healthy Participants

NCT04758234 ·Status: COMPLETED ·Phase: PHASE1

Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers

NCT03837093 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease

NCT06413511 ·Status: WITHDRAWN ·Phase: PHASE1

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

NCT06572384 ·Status: RECRUITING ·Phase: PHASE3

Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis

NCT00005571 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis

NCT05084963 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable Immunodeficiency

NCT02789397 ·Status: WITHDRAWN ·Phase: PHASE2

Biomarkers of Cockroach Sublingual Immunotherapy 2

NCT01380327 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD

NCT00056264 ·Status: COMPLETED ·Phase: PHASE3

Immune Globulin Subcutaenous (Human), 20%

NCT01412385 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis

NCT00690911 ·Status: WITHDRAWN ·Phase: PHASE2